CVS Health, Walmart Settle West Virginia Opioid Lawsuit, Walgreens To Face Trial Next Year – CVS Health (NYSE:CVS)
[ad_1] CVS Health Corp CVS and Walmart Inc WMT will pay $147.5 million to settle lawsuits regarding West Virginia’s opioid crisis, with CVS shelling out $82.5 million and Walmart approximately $65 million.…
Spectrum Plunges After FDA Casts Doubts On Its Lung Cancer Candidate – Spectrum Pharmaceuticals (NASDAQ:SPPI)
[ad_1] Ahead of an adcomm meeting for Spectrum Pharmaceutical Inc SPPI, FDA released briefing documents related to poziotinib for treating patients with previously treated locally advanced or metastatic NSCLC harboring HER2…
Analysts Put Alnylam On Upside Catalyst Watch Ahead Of Upcoming Data From Lead Program – Alnylam Pharmaceuticals (NASDAQ:ALNY)
[ad_1] RBC Capital Markets raised the price target on Alnylam Pharmaceuticals Inc ALNY from $225 to $250. The analyst says that the company is confident that the recent APOLLO-B validates the therapeutic…
Wave Life Sciences Touts Positive Update From Its Lead Huntington’s Program – WAVE Life Sciences (NASDAQ:WVE)
[ad_1] Wave Life Sciences Ltd WVE announced an update to the ongoing Phase 1b/2a SELECT-HD trial of WVE-003 for Huntington’s disease (HD). Eighteen (18) participants have been dosed in…
UK’s NICE Recommends BeiGene’s Cancer Drug For Rare Form Of Blood Cancer – BeiGene (NASDAQ:BGNE)
[ad_1] England’s National Institute for Health and Care Excellence (NICE) has recommended BeiGene Ltd’s BGNE Brukinsa (zanubrutinib) for Waldenström’s Macroglobulinemia (WM) in adults who have had at least one treatment, only if…
Judge Says Yes To $13B UnitedHealth-Change Healthcare Merger: Report – UnitedHealth Group (NYSE:UNH)
[ad_1] A U.S. judge on Monday denied the Justice Department’s request to stop UnitedHealth Group Inc’s UNH $13 billion buyout deal for Change Healthcare Inc CHNG. The Justice Department had filed a…
Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases – Genfit (NASDAQ:GNFT)
[ad_1] Genfit SA GNFT has agreed to acquire the Swiss startup Versantis for CHF40 million upfront in a small-time buyout. The deal, which includes another CHF65 million in milestones, further consolidates…
Beam Therapeutics Touts Encouraging Preclinical Data From Gene Editing Approach For Hepatitis B Infection – Beam Therapeutics (NASDAQ:BEAM)
[ad_1] Beam Therapeutics Inc BEAM announced new preclinical data demonstrating the potential of its multiplex base editing approach to reduce hepatitis B surface antigen (HBsAg) expression and prevent viral rebound of hepatitis…
Bristol Myers’ Opdivo Combo Treatment Scores European Approval For Skin Cancer Setting – Bristol-Myers Squibb (NYSE:BMY)
[ad_1] The European Commission approved Bristol Myers Squibb & Co’s BMY fixed-dose combination of Opdualag (nivolumab and relatlimab) for melanoma patients aged 12 years and above. Melanoma is a form of…
Why Virios Therapeutics (VIRI) Shares Are Plunging Today – Virios Therapeutics (NASDAQ:VIRI)
[ad_1] Virios Therapeutics Inc’s VIRI shares crashed after its FORTRESS Phase 2b trial of IMC-1 antiviral combination therapy for fibromyalgia failed to meet the primary endpoint. Fibromyalgia is a disorder…
Trevi Therapeutics Shares Jump After Complete Data From Chronic Cough Trial – Trevi Therapeutics (NASDAQ:TRVI)
[ad_1] Trevi Therapeutics Inc TRVI announced results from the full set of subjects in its Phase 2 CANAL trial of Haduvio for treating chronic cough in idiopathic pulmonary fibrosis (IPF). Following…
Recent Selloff Is A ‘Buying Opportunity’ For This NASH Stock, Says Analyst – Altimmune (NASDAQ:ALT)
[ad_1] Yesterday, Altimmune Inc ALT announced results from a Phase 1b trial evaluating pemvidutide (ALT-801), a novel glucagonlike peptide-1 (GLP-1) and glucagon dual receptor agonist in non-alcoholic fatty liver disease (NAFLD). According…
Air Canada Joins the List of United Airlines, Mesa Air In Placing Order For Battery Powered Aircrafts – Saab (OTC:SAABY)
[ad_1] Air Canada ACDVF said it would buy electric planes for the first time by acquiring 30 battery-powered regional aircraft from Sweden-based Heart Aerospace. The release did not disclose a value…
Germany Takes Russia’s Rosneft’s Subsidiary Under State Control – Rosneft Oil (OTC:OJSCY)
[ad_1] The German government says it is taking control of Russian oil giant Rosneft’s RNFTF subsidiary in Germany, citing the need to ensure continued operations at three oil refineries and secure…
AstraZeneca’s Blood Clot Treatment Hits Primary Goal In Rare Blood Disorder Trial – AstraZeneca (NASDAQ:AZN), AstraZeneca (OTC:AZNCF)
[ad_1] AstraZeneca Plc AZN said its Danicopan add-on anti-blood-clotting drug met a primary endpoint in the ALPHA phase 3 trial in patients with paroxysmal nocturnal hemoglobinuria (PNH) who experience clinically significant extravascular…
Moderna (NASDAQ:MRNA) – COVID-19 Vaccine Supply To China? Moderna CEO Says Capacity Available
[ad_1] Moderna Inc’s MRNA CEO Stephane Bancel said the company has talked with the Chinese government about supplying COVID-19 vaccines, but no decision has been made, Reuters reported. “We are open, we…
MediciNova (NASDAQ:MNOV) – MediciNova Poised To Receive Canadian Patents For Cholesterol Candidates
[ad_1] MediciNova Inc MNOV received a Notice of Allowance Canadian patent covering MN-001 (tipelukast) and MN-002 (a significant metabolite of MN-001) for hypertriglyceridemia, hypercholesterolemia, and hyperlipoproteinemia. Once issued, the patent maturing…
Pfizer (NYSE:PFE) – Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine
[ad_1] Pfizer Inc PFE has dosed the first participants in the Phase 3 trial of its quadrivalent modified RNA (modRNA) influenza vaccine candidate in approximately 25,000 healthy U.S. adults. Influenza annually…
Akouos (NASDAQ:AKUS) – FDA Clears Akouos’ Gene Therapy Trial For Genetic Form Of Hearing Loss
[ad_1] The FDA has signed off Akouos Inc’s AKUS Investigational New Drug application to initiate a Phase 1/2 trial of AK-OTOF, gene therapy for otoferlin gene (OTOF)-mediated hearing loss. OTOF-mediated hearing…
Atea Pharmaceuticals (NASDAQ:AVIR) – Atea Pharmaceuticals To Advance Global Late-Stage COVID-19 Study of Bemnifosbuvir
[ad_1] Atea Pharmaceuticals Inc AVIR announced additional details on its clinical development plans for bemnifosbuvir for COVID-19. Following meetings with the FDA and the European Medicines Agency Emergency Task Force, Atea…
Cardiff Oncology (NASDAQ:CRDF) – Just After Encouraging Colorectal Cancer Data, Cardiff Oncology Shares Slump, Read Why
[ad_1] Following a strategic review, Cardiff Oncology Inc CRDF has decided it will not independently fund any future clinical activities in metastatic castrate-resistant prostate cancer (mCRPC), citing clinical data and therapeutic…
AbbVie (NYSE:ABBV) – AbbVie Psoriatic Arthritis Drug Shows Long-term Effect On Skin, Joint Symptoms
[ad_1] AbbVie Inc ABBV announced new, long-term data analyses of KEEPsAKE 1 and 2, Phase 3 trials of Skyrizi (risankizumab) in active psoriatic arthritis. Results showed that at week 100 of…
Apple (NASDAQ:AAPL), BYD (OTC:BYDDY) – Top Financial Stories Monday, September 12: Netflix Collaborates With Assassin’s Creed Maker, Gun Sales Could Soon Be Tracked Via Payment Processors, Xi Jinping To Meet Vladimir Putin In First Foreign Trip And More…
[ad_1] Bloomberg Tesla, Nio Supplier CATL’s Chinese Rival Eyes $2B Hong Kong IPO Chinese battery maker CALB Co., a rival to companies like Contemporary Amperex Technology Co Ltd. (CATL)…
Bristol-Myers Squibb (NYSE:BMY) – Bristol Myers’ Deucravacitinib Scores FDA Approval For Plaque Psoriasis
[ad_1] The FDA approved Bristol Myers Squibb Co’s BMY Sotyktu (deucravacitinib), an allosteric tyrosine kinase 2 (TYK2) inhibitor, for moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Sotyktu…
Regeneron Pharmaceuticals (NASDAQ:REGN) – Regeneron’s Bispecific Antibodies Show Encouraging Anti Tumor Activity
[ad_1] Regeneron Pharmaceuticals Inc REGN announced early data for ubamatamab in recurrent ovarian cancer and REGN5093 in MET-altered advanced non-small cell lung cancer (NSCLC). Within 42 patients who received full doses…